Medical Student
Case Western Reserve University School of Medicine
Cyrus Eghtedari is a medical student at Case Western Reserve University School of Medicine and a recipient of the Navy Health Professions Scholarship Program. He graduated from the United States Naval Academy in 2024 with a Bachelor of Science in Chemistry, where he was recognized as a Distinctive Graduate. The class motto at the Academy, “in adversis victoria” remains an important reference point in his academic and professional development.
Eghtedari’s decision to pursue a career in military medicine reflects both personal and professional motivations. Raised in a Navy family and having lived in multiple countries, he was exposed early to the values of service and adaptability. His interest in medicine developed from a desire to extend those values beyond the operational setting, applying them to patient care and research. The combination of these influences led him to pursue the Navy Health Professions Scholarship, with the goal of integrating service, clinical training, and scientific inquiry.
His research interests focus on translational oncology, particularly the development of immunotherapeutic approaches for osteosarcoma. At the Cleveland Clinic Lerner Research Institute, he has characterized HER2 and GD2 expression in osteosarcoma cell lines using immunofluorescence, western blotting, and flow cytometry. He has contributed to studies evaluating the feasibility of bispecific antibodies that redirect T-cell cytotoxicity against osteosarcoma cells, with the aim of addressing therapeutic limitations posed by tumor heterogeneity. In addition to translational work, he is also interested in clinical outcomes research for patients with sarcomas as well as orthopedic conditions, with the goal of identifying strategies that improve long-term function and quality of life.
Outside of academics, Eghtedari is a licensed skydiver with over 100 jumps and previously served on the Naval Academy parachute team. His international upbringing and military background continue to shape his approach to both research and clinical medicine.
